Company Encyclopedia
View More
name
RF Acquisition - UNIT
RFACU.US
News
View More

RF Acquisition Corp. II Held Shareholder Meeting

RF Acquisition Corp. II held a shareholder meeting on November 10, 2025, where shareholders approved amendments to extend the deadline for a business combination and the Investment Management Trust Agreement. A proposal to adjourn the meeting if necessary was also approved. This information was published via EDGAR by RF Acquisition Corp. II.

Reuters·
US
RFAC
0.00%
Reuters·
US
RFAC
0.00%

SPAC RF Acquisition III files for a $100 million IPO, targeting deep tech in APAC

RF Acquisition III, a blank check company focused on deep technology in APAC, has filed with the SEC for a $100 million IPO. The company plans to offer 10 million units at $10 each, with each unit comprising one share of common stock and a right to receive a fraction of a share upon a business combination. Led by CEO Tse Meng Ng, RF Acquisition III aims to target businesses in Asia (excluding China) in sectors like AI, quantum computing, and biotechnology. The company plans to list on Nasdaq under the symbol RFAMU, with EarlyBirdCapital as the bookrunner.

RenaissanceCapital·
US
RFAC
0.00%
US
RFACU
0.00%
RenaissanceCapital·
US
RFAC
0.00%
US
RFACU
0.00%

07:50 ET AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing

Nanyang Biologics Pte. Ltd. has entered into a business combination agreement with RF Acquisition Corp II in a $1.5 billion transaction aimed at pursuing a public listing. The combined company is expected to be listed on Nasdaq under the ticker symbol "NYB." Nanyang Biologics specializes in AI-driven drug discovery, with a focus on developing innovative therapies targeting oncology and other health issues. The company has a strong pipeline, including its flagship candidate NB-A002, and collaborates with Nanyang Technological University to enhance its drug discovery capabilities.

prnewswire·
US
RFAC
0.00%
prnewswire·
US
RFAC
0.00%

The9 Limited’s Investee NYB to Go Public on Nasdaq Through $1.5 Billion Deal with RF Acquisition Corp II

The9 Limited's investee, NYB, is set to go public on Nasdaq through a $1.5 billion merger with RF Acquisition Corp II. Existing shareholders, including The9, will maintain a majority stake and appoint most board members. The deal has board approval and is expected to close in Q1 or Q2 of 2026, pending customary conditions. NYB recently won the 2025 SuperAI Genesis Startup Competition and collaborates with Nvidia, HP, and Equinix on AI-driven drug discovery.

Reuters·
US
NCTY
+5.64%
US
RFAC
0.00%
Reuters·
US
NCTY
+5.64%
US
RFAC
0.00%

RF Acquisition Corp. II Announces Date for Extraordinary General Meeting

RF Acquisition Corp. II will hold an Extraordinary General Meeting on November 10, 2025, at Winston & Strawn LLP in Houston, Texas, with virtual attendance available. Shareholders will vote on several proposals, including the Extension Amendment Proposal, Trust Agreement Amendment Proposal, and Adjournment Proposal. This announcement was generated by Public Technologies and is for informational purposes only, not financial or legal advice.

Reuters·
US
RFAC
0.00%
US
RFACU
0.00%
Reuters·
US
RFAC
0.00%
US
RFACU
0.00%
© 2025 Longbridge｜Disclaimer